These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17117296)

  • 1. Estrogen therapy for postmenopausal osteoporosis.
    Fitzpatrick LA
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):705-19. PubMed ID: 17117296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bones are breaking without estrogen].
    Komulainen M; Tuppurainen M; Kröger H
    Duodecim; 2003; 119(22):2183-9. PubMed ID: 14702807
    [No Abstract]   [Full Text] [Related]  

  • 3. Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.
    Adachi JD
    Can Fam Physician; 1998 Feb; 44():327-32. PubMed ID: 9512836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormones and bone health in postmenopausal women.
    Lindsay R
    Endocrine; 2004 Aug; 24(3):223-30. PubMed ID: 15542889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
    Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
    Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative.
    Jackson RD; Mysiw WJ
    Semin Reprod Med; 2014 Nov; 32(6):454-62. PubMed ID: 25321423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
    Wensel TM; Iranikhah MM; Wilborn TW
    Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens and bone: clinical implications for menopausal women.
    Shoupe D
    Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 2):S329-33. PubMed ID: 10076175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis and fractures in postmenopausal women using estrogen.
    Nelson HD; Rizzo J; Harris E; Cauley J; Ensrud K; Bauer DC; Orwoll E;
    Arch Intern Med; 2002 Nov; 162(20):2278-84. PubMed ID: 12418942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of osteoporosis.
    Mulloy AL; Weinstein RS
    J Med Assoc Ga; 1994 Apr; 83(4):227-30. PubMed ID: 8006552
    [No Abstract]   [Full Text] [Related]  

  • 12. Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.
    Greenspan SL; Emkey RD; Bone HG; Weiss SR; Bell NH; Downs RW; McKeever C; Miller SS; Davidson M; Bolognese MA; Mulloy AL; Heyden N; Wu M; Kaur A; Lombardi A
    Ann Intern Med; 2002 Dec; 137(11):875-83. PubMed ID: 12458987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring aging bones.
    Rosen CJ
    Sci Am; 2003 Mar; 288(3):70-7. PubMed ID: 12616861
    [No Abstract]   [Full Text] [Related]  

  • 14. New possibilities for diagnosis and treatment of osteoporosis.
    Miller PD
    Int J Fertil Womens Med; 2001; 46(4):215-21. PubMed ID: 11563832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What is reliable in the treatment of osteoporosis in menopausal women?].
    Ziegler R
    Internist (Berl); 1993 Jan; 34(1):18-24. PubMed ID: 8440570
    [No Abstract]   [Full Text] [Related]  

  • 16. Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study.
    LaCroix AZ; Cauley JA; Pettinger M; Hsia J; Bauer DC; McGowan J; Chen Z; Lewis CE; McNeeley SG; Passaro MD; Jackson RD
    Ann Intern Med; 2003 Jul; 139(2):97-104. PubMed ID: 12859159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hip fractures: drug therapy.
    Lips P
    Bone; 1996 Mar; 18(3 Suppl):159S-163S. PubMed ID: 8777082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The WHI: the effect of hormone replacement therapy on fracture prevention.
    de Villiers TJ; Stevenson JC
    Climacteric; 2012 Jun; 15(3):263-6. PubMed ID: 22612613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of menopausal hormone therapy in osteoporosis.
    de Villiers T
    Climacteric; 2007 Oct; 10 Suppl 2():71-3. PubMed ID: 17882677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.